Blog
  by

Health Care Leaders Collaborate To Improve Data Usage

As virtual health technologies continue to proliferate, the fragmented nature of the data they generate presents an ever growing challenge. In particular, how best to aggregate and store data accessibly is top of mind for most in the field.  Moreover, translating this data into actionable insights remains a complex challenge.  To this end, representatives from Duke University, Stanford School of Medicine, Kaiser Permanente, Partners Healthcare System, the FDA and other health care organizations, have developed a plan that includes recommendations on how mHealth data can be used by health care organizations to inform diagnoses, care plan creation, and clinical product development.

The group of representatives hope to overcome a challenging conundrum related to mHealth apps. Providers don’t trust data generated by mHealth apps, especially those that are consumer facing, to inform clinical decision making.  Yet, clinicians may have an incomplete view of the patient due to the exclusion of this data.  As a result, this obstacle has prevented many organizations from adopting mHealth apps.

Unsure how to incorporate data into your organization, let alone derive actionable insights from the data that you have? The Sg2 Report: Advanced Analytics: A Foundational Framework can help guide you as you adopt this important tool to support data-driven decision making.

mHealth-Enabled Body Sensors Progress Forward

As organizations explore new ways to embrace the integration and sharing of data, the number of data sources continues to grow. Researchers at MIT, Harvard Medical School, Tufts University and University of Nebraska-Lincoln are currently developing a “smart” bandage that will be able to deliver time-release doses of medication into wounds. The project, entitled, The Dermal Abyss Program, envisions a bandage made of gel-coated fibers containing medications which would be released by a microcontroller embedded in the bandage controlled by a mHealth app.

The initiative is the latest step toward overcoming the limitations of wearables. From “smart” tattoos to patches and beyond, the possible applications of these “body sensors” are far-reaching. For more on this subject, refer to Sg2’s publication, The Next-Generation Technology Platform. Not an Sg2 member? Contact us to learn more.

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube